Physician profile
Robert Y Rhee
NPI 1669448528
$337,593.74
in general payments reported to CMS, 2019-2025
30 companies · $44K in 2025
The $44K reported for 2025 was more than what 98% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $56K · 2020: $72K · 2021: $37K · 2022: $51K · 2023: $34K · 2024: $43K · 2025: $44K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $105K · Food and Beverage: $10K · Travel and Lodging: $6,702 · Education: $5.75.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $104,963.75 |
| Food and Beverage | $10,078.71 |
| Travel and Lodging | $6,701.91 |
| Education | $5.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $254,601.51 | 2019-2025 | Product In Development, Excluder Conformable Aaa Endoprosthesis With Active Control, Gore Tag Thoracic Branch Endoprosthesis |
| Boston Scientific Corporation | $34,248.41 | 2019-2025 | General - Therapies, Enroute Transcarotid Neuroprotection System, General - Angiography |
| Ge Healthcare | $22,150.05 | 2019-2025 | |
| Endologix LLC | $10,257.84 | 2019-2024 | Endocross Device, Torus Stent Graft System |
| Abbott Laboratories | $2,836.29 | 2019-2025 | Esprit, Diamondback Peripheral, Jeti Peripheral Catheter |
| Cook Incorporated | $2,640.82 | 2019 | |
| Cook Medical LLC | $2,164.38 | 2019-2025 | Cook, Zenith Spiral-Z, Zenith Alpha |
| Bard Peripheral Vascular, INC. | $1,890.70 | 2019-2024 | Lutonix Drug Coated Balloon, Venovo |
| Cvrx, INC. | $1,228.49 | 2021-2023 | Barostim Neo System |
| Bolton Medical INC | $1,168.56 | 2019-2023 | Treo Abdominal Stent-Graft System |
| Medtronic, INC. | $1,125.62 | 2021-2025 | Endurant Iis, Ellipsys Vascular Access System, Valiant Captivia |
| Silk Road Medical, INC. | $835.95 | 2021-2023 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent |
| Medtronic Vascular, INC. | $795.61 | 2019-2020 | |
| Penumbra, INC. | $404.99 | 2021-2024 | Indigo System, Penumbra System |
| Inari Medical, INC. | $337.90 | 2020-2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $225.86 | 2023-2025 | Floseal, Tisseel |
| Shockwave Medical, INC | $216.53 | 2019-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Terumo Medical Corporation | $65.23 | 2023-2025 | Azur Cx Detachable, Angio-Seal |
| Innovation Technologies INC | $58.33 | 2025 | Irrisept |
| Stryker Corporation | $48.78 | 2025 | Artix Mt |
| Organogenesis INC. | $47.51 | 2022-2024 | Nushield |
| Ethicon US, LLC | $47.00 | 2025 | Ethicon |
| Angiodynamics, INC. | $45.41 | 2019-2024 | Venacure 1470 Pro |
| Integra Lifesciences Corporation | $37.96 | 2019-2020 | |
| Lemaitre Vascular, INC. | $26.13 | 2022 | |
| Janssen Pharmaceuticals, INC | $25.11 | 2021 | |
| Acera Surgical, INC. | $19.14 | 2025 | Restrata Wound Matrix |
| Argon Medical Devices, INC. | $16.74 | 2025 | Clot Management |
| Sirtex Medical INC | $15.24 | 2025 | Sir-Spheres Microspheres |
| Covidien Lp | $11.65 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Rhee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.